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Admixture mapping (also known as “mapping by admixture linkage disequilibrium,” or MALD) provides a way
of localizing genes that cause disease, in admixed ethnic groups such as African Americans, with ∼100 times fewer
markers than are required for whole-genome haplotype scans. However, it has not been possible to performpowerful
scans with admixture mapping because the method requires a dense map of validated markers known to have large
frequency differences between Europeans and Africans. To create such a map, we screened through databases
containing ∼450,000 single-nucleotide polymorphisms (SNPs) for which frequencies had been estimated in African
and European population samples. We experimentally conﬁrmed the frequencies of the most promising SNPs in a
multiethnic panel of unrelated samples and identiﬁed 3,011 as a MALD map (1.2 cM average spacing). We estimate
that this map is ∼70% informative in differentiating African versus European origins of chromosomal segments.
This map provides a practical and powerful tool, which is freely available without restriction, for screening for
disease genes in African American patient cohorts. The map is especially appropriate for those diseases that differ
in incidence between the parental African and European populations.
Introduction
Admixture mapping (also known as “mapping by ad-
mixture linkage disequilibrium,” or MALD) offers an
approach for performing a whole-genome linkage dis-
equilibrium (LD)–based association scan at a fraction of
the cost of haplotype or direct association mapping
(Chakraborty and Weiss 1988; Risch 1992; Briscoe et
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al. 1994; Stephens et al. 1994; McKeigue 1997, 1998;
Zheng and Elston 1999; McKeigue et al. 2000; Lauten-
berger et al. 2000; Pfaff et al. 2001; Smith et al. 2001;
Halder and Shriver 2003; Hoggart et al. 2003). The idea
of admixture mapping is to screen along the genome in
patients such as African Americans or Hispanic Amer-
icans, whose genomes have chromosomal segments of
different origins because of historic gene ﬂow between
different ethnic groups (e.g., African, European, and
American Indian). The strategy is to identify a genomic
region with an unusually high contribution of ancestry
from one ancestral population, usually the population
with the highest incidence of disease. Admixture map-
ping is expected to be particularly powerful for ﬁnding
genes for diseases that differ strikingly in frequency
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Table 1
Sources for SNPs Used To Build the Map
SOURCEa
NO. OF SNPS IN
Entire
Database
Validated
Map of
3,011
Reduced
Map of
2,154
TaqMan Assays-On-Demand SNP Genotyping Products database (De La Vega et al. 2002) 177,781 1,913 1,316
The SNP Consortium Allele Frequency Project (SNP Consortium Web site) 54,824 759 592
Applera Genomics Initiative exon resequencing database (Adams et al. 2002)b 266,135 304 219
Previously identiﬁed as informative for admixture analysis (Parra et al. 1998) 18 14 13
SNPs culled by D.R. from random published sources (especially Reich et al. 2003) and unpublished data 1,348 14 9
SeattleSNPs discovered by resequencing genes (UW-FHCRC Variation Discovery Resource Web site) 6,305 7 5
Totalb ∼450,000 3,011 2,154
a Many SNPs had allele frequency information submitted from multiple sources. To create a nonredundant entry, we included frequency data
only from the source in which the most samples were genotyped.
b Only 10,530 SNPs from the Applera gene resequencing database, those with SIC 10.1, were in the actual list from which SNPs were selected.
This meant that the total number of SNPs in the list we analyzed was 250,806; however, the effective number used for choosing differentiated
markers was thus larger, ∼450,000.
across populations, because of the possibility that there
may be genetic loci that underlie these differences. For
example, multiple sclerosis is a good candidate for ad-
mixture mapping, because it is heritable and has a much
higher genetic risk in European than African Americans
(Kurtzke et al. 1979), and prostate cancer and end-stage
renal disease are good candidates because their inci-
dences are higher in people of African descent (Klag et
al. 1997; Davey Smith et al. 1998).
The key advantage of admixture mapping is that it
requires the study of substantially fewer genetic mark-
ers than do other methods of association mapping
(haplotype or direct association studies). Because of
the recent admixture of African Americans (within the
last 20 generations), their genomes have not been shuf-
ﬂed much by recombination since population mixing
began, and the stretches of identical ancestry should
be many megabases in extent. As a result, although
105–106 markers may be necessary for whole-genome
haplotype studies (Gabriel et al. 2002; Carlson et al.
2003), a couple thousand MALD markers typed in an
admixed population cohort should be adequate to as-
sess ancestry information genomewide.
Admixture mapping has not yet been successfully used
to identify a disease gene, although theoretical and em-
pirical studies of feasibility are encouraging (Chakraborty
and Weiss 1988; Risch 1992; Briscoe et al. 1994; Ste-
phens et al. 1994; McKeigue 1997, 1998; Zheng and
Elston 1999; Lautenberger et al. 2000; McKeigue et al.
2000; Pfaff et al. 2001; Smith et al. 2001; Halder and
Shriver 2003; Hoggart et al. 2003; Rosenberg et al. 2003;
Patterson et al. 2004 [in this issue]). A major reason for
the lack of results so far is that there has been limited
availability of highly informative MALD markers—that
is, thosewith known large differences in allele frequencies
across major ethnic groups. Recently, the genotyping of
hundreds of thousands of SNPs from several populations
has improved the prospects for admixturemapping.Here
we describe a high-density map of 3,011 SNPs, !1% of
the screening database, that have been validated in a
second and independent set of samples. In the accom-
panying article (Patterson et al. 2004 [in this issue]), we
present methods that efﬁciently combine the information
from neighboring, partially informativemarkers, tomake
estimates of ancestry that are suitable for disease gene
discovery. The highly differentiated markers validated in
this study, as well as the new methods, should facilitate
admixture mapping as a powerful method for disease
gene localization.
Methods
Building a Large Database of SNPs from Which
to Choose an Admixture Map
The key resource for building an admixture map in
African Americans is a very large database of genetic
variants for which allele frequencies are known in pop-
ulations of both European and African descent (table
1). Although most genetic variants have similar fre-
quencies in these ancestral populations (Lewontin 1972;
Nei and Roychoudhury 1982), a small fraction have
large enough differences to be useful for admixture
mapping.
We combined SNPs from public and private databases
to obtain a list of nonredundant markers with frequen-
cies known in populations of both European and African
descent (table 1). For each SNP, we recorded the fre-
quencies, number of samples genotyped, physical posi-
tion in the HG16 public genome assembly, and genetic
position in the deCODE map (Kong et al. 2002). We
eliminated SNPs from analysis if they appeared to have
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discrepant physical and genetic positions (that is, if they
were within 100 kb on the physical map but appeared
10.5 cM apart on the genetic map).
Choosing Candidate SNPs for Follow-Up Experimental
Validation
A computer program was written to select the best
SNPs for admixture mapping from the database. The
program chooses SNPs that are (1) evenly spaced on the
genetic map and (2) maximally informative about an-
cestry at each point along the genome, in the sense of
having high allele frequency differentiation. Thus, it at-
tempts to choose an optimal set of SNPs for estimating
ancestry at each point in the genome.
We implemented an iterative “greedy algorithm” to
choose markers in the map. The algorithm repeatedly
chooses the SNP that adds the most additional infor-
mation to the set that has already been identiﬁed, taking
into account the fact that some information may already
be provided at the site of a candidate SNP by markers
already chosen for the map. For simplicity, we make the
approximation that all markers in an 8-cMwindow cen-
tered on the candidate SNP are fully “linked for ad-
mixture” and thus can be treated as a compound locus
for the purpose of ancestry inference. We also assume
that more-distant markers provide no information.
To assess how much additional information is pro-
vided by a candidate SNP, we calculated the mutual in-
formation (McEliece 2002) provided about ancestry
with the candidate MALD marker added in, minus the
information only from nearby markers. The formula for
a multimarker genotype is similar to the Rosenberg et
al. (2003) equation for “informativeness for assign-
ment.” When a candidate SNP is considered alone or is
14 cM from any other SNPs, it is simply
( )Shannon InformationContent SIC
1
( ) ( )p a  a log a  a i0 i1 i0 i1
ip0
1
( ) ( ) a  a log a  a 0j 1j 0j 1j
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1 1
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pWA are the SNP frequencies in European Americans and
West Africans, and m is the proportion of European
ancestry in African Americans, which we set to 0.21,
although we found that SNP selection is not very sen-
sitive to the choice of m. For the many SNPs in our data
set for which no West African frequencies were avail-
able, we used an expectation-maximization algorithm
(Dempster et al. 1977) to infer them from the African
American frequencies.
The greedy algorithm described above was iteratively
applied, each time choosing new markers for the map
until the additional information provided by the SNP
(SIC) fell below 0.035, at which point the algorithm
terminated. Three additional criteria were applied for
SNP selection:
1. Candidate SNPs were chosen for the map only if
they were spaced at least 50 kb from all previously
chosen ones.
2. The estimates of frequencies from the databases
were adjusted to account for the fact that some
SNPs may appear to be more attractive for ad-
mixture mapping simply because they are picked
as the most extreme cases of differentiation from
a database in which there is sampling ﬂuctuation.
Speciﬁcally, before applying the SNP selection al-
gorithm, 1 was added to both the minor and major
allele counts in the populations of European and
African descent, to make their frequencies appear
more similar. For SNPs with frequencies from less
reliable pooled genotyping, the differentiation was
reduced further by adding 25% to both the major
and minor allele frequencies.
3. Finally, the estimates of frequencies were adjusted
by transforming all estimates so that they were 7%
closer to 0.5. This procedure encouraged the pro-
gram to choose markers for the map even near the
most informative SNPs, which is important because
it means the map will have some power even if there
are missing genotypes.
Procedure for Experimentally Validating SNPs
All SNPs in the map were revalidated by genotyping
new population samples to determine their allele fre-
quencies. Validation of SNPs was performed at two lab-
oratories. About half were validated at the National
Cancer Institute’s Laboratory of Genomic Diversity
(Laboratory of Genomic Diversity Web site) in Mary-
land by the 5′ nuclease assay (TaqMan Assays-on-
Demand or Assays-by-Design SNP Genotyping Products
[Applied Biosystems]) (Livak 1999), and about half were
genotyped at the Broad Institute in Massachusetts by
primer-oligo base extension assay resolved by MALDI-
TOF mass spectrometry on a chip (MassARRAY [Se-
quenom]) (Tang et al. 1999). A total of 3,340 SNPs were
experimentally genotyped during the validation process,
although, as described below, only a subset of 3,011
were considered robust enough to be included in the
complete map and presented in table A (online only).
The greatmajority of revalidated SNPs (2,991 of 3,340)
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Table 2
Characteristics of Samples
SAMPLE EXAMINED n
POPULATION CONTRIBUTION
ASSESSED BY STRUCTUREa
(%)
European African Asian Amerindian
European American:
Chicagob 39 98.4 .4 .7 .5
Baltimoreb 39 97.5 .4 .9 1.3
African American:
Chicagob,c 18 18.4 80.6 .7 .3
Pittsburghb,c 23 18.3 80.6 .6 .5
Baltimored 45 15.9 83.2 .5 .5
North Carolinac 23 18.8 79.6 .5 1.1
African:
Senegale 46 2.8 95 1.6 .6
Ghanaf 33 .1 99.8 .1 .1
Cameroong 20 .1 99.8 .1 .1
Botswanah 21 1.2 98.4 .3 .1
Chinese:
Cantonesei 40 .2 .1 98.9 .8
Amerindian:
Mexican Zapotecj 29 4.3 .3 .5 94.8
a The STRUCTURE analysis (Falush et al. 2003) was based on the
2,034 SNPs from the reduced 2,154-marker map that were genotyped
in the samples above. The relative log likelihoods for the two-, three-,
four-, ﬁve-, and six-population models in STRUCTURE (Falush et al.
2003) were25055,6612, 0,756, and667, respectively.We used
a four-population model because it is most probable given the data.
b From the Multicenter AIDS Cohort Study (Kaslow et al. 1987).
c From the Multicenter Hemophilia Cohort Study (Goedert et al.
2002).
d From the AIDS Link to Intravenous Experiences study (Vlahov et
al. 1998).
e Sample from J.-L.S..
f Sample from S.M.W.
g Sample from S.A.T. (Tishkoff and Williams 2002).
h Sample from M.E. (Novitsky et al. 2001).
i Sample from Z.Y., G.T., and S.O. (unpublished data).
j Sample from Hollenbach et al. 2001.
were genotyped in 78 EuropeanAmericans (fromChicago
or Baltimore), 120 sub-Saharan Africans (from Senegal,
Ghana, Cameroon, or Botswana), 109 African Americans
(from Chicago, Baltimore, Pittsburgh, or North Caro-
lina), 40 Cantonese Chinese, and 29 Mexican Amerin-
dians (table 2). For 1,136 SNPs (including 349 not studied
in the main panel of samples), 78 European Americans
(CEPH) and 73 sub-Saharan Africans (Beni fromNigeria)
were genotyped. All samples were collected under insti-
tutional review board approval with informed consent for
the genetic study at each collection site.
Identifying a Subset of SNPs That Should Be Included
in MALD Mapping Panels
Validated SNPs were included in the complete 3,011-
marker map if they:
1. were genotyped successfully in at least 20 West
Africans and 20 European Americans;
2. were in Hardy-Weinberg equilibrium in the parental
populations ( by G test summing over allP 1 .005
European American and West African populations
for which data were available and a Hardy-Wein-
berg statistic could be calculated);
3. had a minimal level of informativeness (SIC 10.035
according to eq. [1], out of a maximum of 0.709)
at the FY-null locus (also known as “Duffy”); and
4. were similar in frequency within continents (P 1
in aG test in sub-Saharan African populations,.002
excluding the more distantly related Botswana pop-
ulation, and in European Americans).P 1 .002
Admixture Mapping Panel Free of Historic LD
Additional SNPs with low information were elimi-
nated until the following were satisﬁed:
5. all SNPs in the map were spaced at least 50 kb
from each other, and
6. all SNPs in the map were not in LD with any of the
other SNPs ( not correcting for multipleP 1 .0005
hypothesis testing) in the parental populations.
Evaluating the Power of the Map
The power to detect a disease locus through use of
admixture mapping depends on two independent fac-
tors. First, there is the strength of the disease locus for
which one is searching: the enrichment of one popula-
tion’s ancestry at that point in the genome. The accom-
panying article by Patterson et al. (2004 [in this issue])
explores in detail how disease model affects the power
of a study. Second, there is the quality of the map: how
well one is able to estimate origins of chromosomal seg-
ments from genotyping data.
To analyze the quality of the map, we used an analysis
described in detail in the appendix (online only). In brief,
“map power” is calculated as a quotient: the number of
samples required, given the imperfect map, divided by
the number that would be necessary if one had a per-
fectly informative marker at every site. For example, at
a point where map power is 1/3, one needs 3 times the
sample size as would be necessary if one were trying to
detect a locus near a marker (such as FY null) with full
map power: where genotypes provide deﬁnitive infor-
mation about whether patients have 0, 1, or 2 European-
ancestry alleles. In practice, map power was calculated
by simulating data sets containing a disease locus and
evaluating how many samples were necessary to detect
it with a given level of power, compared with a perfectly
informative marker such as FY null (see the appendix
[online only]).
The map power calculation is somewhat overoptimis-
tic, in that it assumes that the frequencies of alleles in
parental populations are known perfectly, but inaccura-
cies in these measurements may in fact reduce power.
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Extensive simulations were used to explore the impor-
tance of this effect. We found, for example, that a locus
with a calculated map power of 70% may provide only
50% of the information of the FY null locus (see ﬁg. 7
of Patterson et al. 2004 [in this issue]).
Data Analysis to Assess Admixture Mapping
Parameters and Population Structure
The analysis from Patterson et al. (2004 [in this is-
sue]), which is implemented in the software packageAN-
CESTRYMAP, was used to estimate admixture mapping
parameters. The STRUCTURE program (Pritchard et al.
2000) was employed to assess the relative contributions
of different populations to the multiethnic data set, using
admixture LD between markers as the basis for the in-
ference (Falush et al. 2003).
Results
A Database of SNPs for Marker Selection
The SNPs for building the admixture map came from
publicly available sources (mostly in dbSNP), as well as
two commercial databases (Adams et al. 2002; De La
Vega et al. 2002; Applied Biosystems myScienceWeb site)
(table 1). The Applied Biosystems database consisted of
177,781 SNPs genotyped in 46 European Americans and
45 African Americans. These data were obtained while
developing the Applied Biosystems TaqMan Assays-on-
Demand Genotyping Products (De La Vega et al. 2002).
The Applera Genomics Initiative database consisted of
266,135 SNPs discovered in 20 European Americans and
19 African Americans by resequencing exonic and pro-
moter regions around 23,363 annotated human genes
(Adams et al. 2002). The total size of the SNP collection
that we mined to obtain maximally informative markers
for African American admixture mapping was ∼450,000
(table 1).
Selection of MALD Marker SNPs and Experimental
Validation
After each round of SNP selection and genotyping
(typically 300–1,200 SNPs), the database was updated
with the revised frequencies of the SNPs that were now
validated, and the program was run again to select new
SNPs. This iterative procedure made it possible to ﬁll in
holes in the map and to utilize new SNP allele frequencies
from public and proprietary databases as they became
available over the course of the project. Overall, 1,537
SNPs were genotyped only at the Laboratory of Ge-
nomic Diversity (1.3% missing data rate), and 1,770
SNPs were genotyped only at the Broad Institute (2.9%
missing data rate). Of the 33 SNPs genotyped at both
sites, 61 discrepancies were observed out of 11,847 ge-
notypes obtained at least in duplicate (0.51%). This in-
dicates an average error rate of ∼0.26%.
Selection of 3,011 Markers with High Frequency
Differentiation across Populations
From the 3,340 experimentally revalidated SNPs, we
selected 3,011 that are maximally informative for ad-
mixture mapping (table 1; also see table A [online only],
a tab-delimited ASCII ﬁle that can be imported into a
spreadsheet). The median allele frequency difference be-
tween West Africans and European Americans is 56%,
and the median SIC according to equation (1) is 25%
of the maximum. The allele frequency estimates ob-
tained by our revalidation genotyping in each ethnic
group, the map positions, and the ﬂanking sequences for
the SNPs are all presented in table A (online only). All
markers in this map are freely and publicly available
without restriction, and genotypes are available on re-
quest. Chromosomal maps, ﬁgures showing the posi-
tions of each of the MALD markers in the genome, are
available from the Laboratory of Genomic Diversity
Web site.
Power of 2,154 Widely Spaced Markers for Admixture
Mapping
We further selected 2,154 SNPs that are optimized for
current admixture mapping analysis strategies (e.g., Fa-
lush et al. 2003; Patterson et al. 2004 [in this issue]), in
the sense of having no LD among them in the parental
African and European populations. We calculated the
power of this panel for admixture mapping, where map
power is deﬁned (as above) as the information provided
by the map about ancestry at a given point in the ge-
nome, compared with what would be obtained from
genotyping a 100% informative marker that perfectly
differentiates between populations.
When we assess the power in African Americans, the
average map power for a random position in the genome
is of the maximum (mean SD) (ﬁgs. 1 and71% 9%
2). The power for 50%-50% mixtures of Africans-
Amerindians is , for Europeans-Amerindians66% 11%
is , and for Europeans–East Asians is30% 11%
. The fact that East Asians are slightly more36% 11%
distinctive than Amerindians as compared with Europe-
ans may reﬂect a small amount of confounding European
admixture among the Amerindian samples (table 2).
Figure 2 presents the distribution of map power across
the genome. Because the average information content ex-
tracted from African American samples is 71%, at an
average locus one needs to study times as1/0.71p 1.4
many samples to detect disease genes as would be nec-
essary if one had full ancestry information. Uncertainties
in the frequencies in the parental populations, however,
mean that, in practice, these estimates are overoptimistic
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Figure 1 Power of the individual 2,154 MALD markers (white bars), as a fraction of the maximum (power is calculated by eq. [1]).
Power increases strikingly when the methods described by Patterson et al. (2004 [in this issue]) are used to combine data from multiple, closely
linked markers (black bars).
(see the “Methods” section and Patterson et al. 2004 [in
this issue]). The true information content is ∼50%, com-
parable to the power of standard linkage maps (M. Daly,
personal communication). Admixture genome scans using
the present 2,154-marker map should therefore have dou-
ble the sample size than would be necessary with a “per-
fect admixture map” in which every marker was as max-
imally differentiated as the FY null allele between the
parental African and European populations. Calculations
for such a “perfect admixture map,” for various disease
models, are presented in the article by Patterson et al.
(2004 [in this issue]). Power would be improved if extra
information were incorporated from the full 3,011-
marker map.
Subsets of SNPs for Estimating Population Ancestry
A subset of MALD markers can be genotyped to es-
timate the proportion of ancestry for each individual in
a study (Parra et al. 1998). Genotyping such panels of
markers allows researchers to search for evidence of ge-
netic risk for a disease being higher in one ancestral
population than another. For example, prostate cancer
(Kittles et al. 2002), BMI (Fernandez et al. 2003), lupus
(Molokhia et al. 2003), and several other traits (Halder
and Shriver 2003) have all been genetically associated
with the proportion of African ancestry. Estimating an-
cestry proportions in individuals is also useful for con-
trolling for population stratiﬁcation—systematic differ-
ences in ancestry between cases and controls—which can
cause false positives in association studies (Pfaff et al.
2002; Hoggart et al. 2003; Freedman et al. 2004).
Table B (online only), a tab-delimited ASCII ﬁle that
can be imported into a spreadsheet, provides lists of 100
SNPs spaced by at least 25 cM that are optimal for
distinguishing four different mixtures and for making
precise ancestry estimates. The average differences in al-
lele frequencies are 78% (for African/European mix-
ture), 85% (for African/American Indian mixture), 56%
(for European/American Indian mixture), and 57% (for
European/East Asian mixture).
Estimates of Admixture Mapping Parameters
from the Genotyping Data in this Study
The ANCESTRYMAP software described in the ac-
companying article by Patterson et al. (2004 [in this
issue]) was used to estimate parameters relevant to ad-
mixture mapping. First, the range of proportions of Eu-
ropean ancestry was estimated for the 109 African
American samples in this study (ﬁg 3A). The range of
estimates is (mean  SD), slightly lower20% 8%
than the estimate of for 718 unrelated sam-21% 11%
ples from the study by Patterson et al. (2004 [in this
issue]). We note that 95% of the samples in this study
are estimated to have 10%–90% European ancestry, in
the range of maximal power for admixture mapping
(Patterson et al. 2004 [in this issue]).
Second, we estimated the number of generations since
admixture for each individual (ﬁg. 3B). Since gene ﬂow
between European Americans and African Americans
has occurred over many generations, the estimated num-
ber of generations since admixture should, in fact, be
interpreted as an average across a person’s different line-
ages (Stephens et al. 1994; Pfaff et al. 2001).We estimate
generations since admixture for these 1096.3 1.1
Figure 2 Power of the 2,154-marker map as a fraction of what would be expected if there was full information about ancestry available
at every point (e.g., nearly complete information [a value of 1 on the Y-axis] is available at Duffy on chromosome 1, indicated by a star). The
black line is the power of the African American map under the assumption of an average of six generations since admixture (the power would
be lower for individuals with more generations since admixture). We were also able to roughly estimate the quality of the map for studies
involving Amerindian and East Asian mixtures under the assumption of six generations since admixture, although these estimates are less reliable
because the sample sizes were smaller.
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Figure 3 A, Distribution of percentage of European ancestry (Mi) in 109 African American samples genotyped at 2,154 MALD markers
(mean  SD p 20%  8%). B, Distribution of estimated number of generations since admixture (li) for 109 African Americans (mean 
SD p 6.3  1.1). All estimates are generated by the ANCESTRYMAP software from the accompanying article by Patterson et al. (2004 [in
this issue]). We emphasize that the number of “generations since admixture” is an average across a person’s lineages, since mixing between
Africans and Europeans has occurred over many generations.
samples, which is similar to the result of for6.0 1.6
the 718 samples studied by Patterson et al. (2004 [in
this issue]). We used this to estimate the probability of
no recombination since admixture between a disease lo-
cus and neighboring sites; that is, the extent of admixture
LD in the African American population (ﬁg. 4). A peak
of association is expected to fall to half its maximum
LOD score within 11 cM of a disease locus, consistent
with previous estimates of 10–20 cM for strong admix-
ture LD in African Americans (Parra et al. 1998; Lau-
tenberger et al. 2000; Collins-Schramm et al. 2003; Fa-
lush et al. 2003; Patterson et al. 2004 [in this issue]).
Third, we applied the Patterson et al. (2004 [in this
issue]) analytic approach to chromosome 1 for 5 African
American individuals, each with different percentages of
European ancestry, selected from the 109 in this study.
The analysis demonstrates clear transitions between seg-
ments of 0, 1, or 2 European alleles, with stretches of
European and African ancestry extending for tens of
megabases (ﬁg. 5). To screen for disease genes on the
basis of such data, the Patterson et al. (2004 [in this
issue]) ANCESTRYMAP software combines these esti-
mates across many individuals, searching for regions
where the average proportion of African ancestry is
higher (or lower) than the genomewide average.
Fourth and ﬁnally, application of the ANCESTRY-
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Figure 4 Predicted probability of no recombination having oc-
curred since admixture between a disease locus and a nearby marker
locus, predicting the shape of a peak of association in an African
American admixture study. The analysis was based on the distribution
of the estimated number of generations since admixture (li) values
estimated from 109 African Americans (ﬁg. 3B). We present the prob-
ability of a crossover between ancestry segments, as a function of the
distance between a disease locus and mapping marker. At 4.5 cM, we
expect the strength of association to drop to 75% of its maximum
(measured as LOD or log of the P value). At 11 cM and 23 cM, the
power drops to 50% and 25% of its maximum, respectively.
MAP software allowed us to assess how closely theWest
African and European American populations corre-
sponded to the true parental populations for African
Americans. The software can estimate a parameter tE
for Europeans and tA for Africans, indicating how much
drift has occurred between the parental population and
actual European American and West African samples
that have been genotyped. An interpretation of tE and
tA is that the true frequencies in the parental populations
of African Americans are as close to those in the Eu-
ropean American and West African controls as would
be expected if the control sample frequencies were ob-
tained by sampling tE alleles and tA alleles from the an-
cestral African American populations (e.g., Nicholson et
al. 2002). The West Africans and European Americans
are fairly close to the parental populations ( ;t p 135E
). For example, this means that if the true allelet p 242A
frequency of a SNP in the African ancestors of an African
American sample was 30%, its frequency in the West
African samples studied here is 95% likely to be in the
range of 27%–33%. This is encouraging for potential
applications of admixture mapping, but not surprising.
As has been previously observed (Collins-Schramm et al.
2003), there is remarkable similarity in allele frequencies
across all of West Africa, which is thought to be the
source population for African Americans (perhaps be-
cause of the Bantu expansion across West Africa within
the past 5,000 years). In addition, the 2,154 MALD
markers chosen for the map were speciﬁcally selected
not to differ strikingly in frequency across West African
or European American populations, to minimize within-
continent allele frequency divergences.
Analysis of Population Structure from the Genotyping
Data
The STRUCTURE program (Pritchard et al. 2000;
Falush et al. 2003), which clusters individuals into pop-
ulations based on characteristic LD patterns between
linked and unlinked loci, was used to assess population
differentiation on the basis of the genotyping data from
the main panel of 376 samples (table 2). The STRUC-
TURE analysis strongly supports the partition into four
ancestral populations, corresponding to West Africans,
Europeans, American Indians, and East Asians (table 2).
The four African American populations were estimated
to have 16%–19% European ancestry, consistent with
the estimates of Parra et al. (1998). Modest admixture
is also inferred for the other populations (e.g., European
admixture in Amerindians and European admixture in
Senegal and Botswana), although STRUCTURE does
not provide statistical conﬁdence about the presence of
admixture.
Discussion
We have developed a high-density admixture map for
studies in African Americans. This map contains 3,011
highly differentiated SNPs that are about ﬁve times more
informative, on average, than a random microsatellite
(Smith et al. 2001; Rosenberg et al. 2003). In the accom-
panying article (Patterson et al. 2004 [in this issue]), we
present a method that allows for efﬁcient use of this map.
Other analysis methods, including those of McKeigue
(1997, 1998) and Hoggart et al. (2003), as well as
straightforward association tests (Chakraborty andWeiss
1988; Stephens et al. 1994), will also beneﬁt from the
admixture map. Diseases with strikingly different risks in
populations of African and European descent (table 3)
are particularly promising for admixture mapping in Af-
rican Americans, as long as the difference in risk has a
genetic underpinning and is not entirely due to environ-
mental inﬂuences.
Comparable resources for admixture mapping in His-
panic populations or in Asian admixed groups are not
yet available. Candidate SNPs have been identiﬁed by
Parra et al. (1998) and Collins-Schramm et al. (2004),
and our map contains several hundred markers that
appear to be highly informative for both Hispanic and
Asian admixture mapping (ﬁg. 2). To build dense maps
comparable to the one presented here for African Amer-
icans, it will be necessary to ﬁrst mine large databases,
such as those being developed in the international hap-
lotype map project (International HapMap Consortium
Figure 5 Estimates of ancestry along chromosome 1 for ﬁve African American samples, estimated by use of the Patterson et al. (2004
[in this issue]) ANCESTRYMAP software. The positions of the 169 markers in the map on chromosome 1 that were used for this inference
are indicated by hash marks (inferred European chromosome segments are indicated by black bars). Sharp transitions between segments of 0,
1, or 2 European alleles are clear from the analysis, indicating the high resolution of the map.
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Table 3
Candidate Diseases for Admixture Mapping in African Americans
Disease Relative Risk (95% CI) Reference
Hepatitis C clearance .19 (.10–.38) Thomas et al. 2000
HIV vertical transmission .30 (.10–.90) Tess et al. 1998
Multiple sclerosis .45 (.35–.55) Kurtzke et al. 1979
Lung cancer 1.48 (1.38–1.67) Davey Smith et al. 1998
Stroke 1.57 (1.27–1.94) Davey Smith et al. 1998
End-stage renal disease 1.87 (1.47–2.39) Klag et al. 1997
Intracranial hemorrhage 2.10 (1.44–3.06) Davey Smith et al. 1998
Focal segmental glomerulosclerosis 2.43 (1.09–5.45) Lopes et al. 1999
Prostate cancer 2.73 (2.13–3.52) Davey Smith et al. 1998
Hypertensive heart disease 2.80 (2.03–3.86) Davey Smith et al. 1998
Myeloma 3.14 (2.00–4.93) Davey Smith et al. 1998
NOTE.—Relative risks given are for African Americans versus European Americans. Ad-
mixture mapping may also work for diseases with small incidence differences between
African Americans and European Americans, because the risk may be differently distributed
over loci. However, these should not be the ﬁrst diseases to which the method is applied.
2003), and then to validate candidate SNPs in a new
and diverse sample set representative of the ancestral
populations of Hispanic American and admixed Asian
populations. The resulting marker maps will provide a
powerful resource for admixture mapping of high-
incidence disease-causing alleles in these populations.
The map of MALD markers that we have described
and the methods presented in the accompanying article
(Patterson et al. 2004 [in this issue]) now make high-
density admixture mapping in African Americans prac-
tical. However, no new disease gene has ever been iden-
tiﬁed by admixture mapping, so validation of the
approach will require the study of large collections of
unrelated patients affected by disease. Only a few thou-
sand markers need to be genotyped to perform a pow-
erful admixture mapping study, and, thus, a whole-
genome scan is practical with current technologies.
Admixture mapping can, in theory, localize disease var-
iants that differ strikingly in frequency across popula-
tions, to within 5–10 cM (ﬁg. 4). This is a ﬁner scale
than linkage mapping but much rougher than haplo-
type-based association mapping. We conclude that ad-
mixture mapping provides a major new practical ad-
dition to the approaches available for discovering novel
genes underlying the development of complex diseases.
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